Brown Advisory Securities’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-275,000
| Closed | -$1.2M | – | 287 |
|
2021
Q2 | $1.2M | Hold |
275,000
| – | – | 0.19% | 84 |
|
2021
Q1 | $1.13M | Hold |
275,000
| – | – | 0.19% | 85 |
|
2020
Q4 | $1.1M | Hold |
275,000
| – | – | 0.19% | 83 |
|
2020
Q3 | $743K | Hold |
275,000
| – | – | 0.15% | 98 |
|
2020
Q2 | $729K | Hold |
275,000
| – | – | 0.16% | 95 |
|
2020
Q1 | $624K | Hold |
275,000
| – | – | 0.16% | 107 |
|
2019
Q4 | $1.29M | Hold |
275,000
| – | – | 0.31% | 75 |
|
2019
Q3 | $920K | Hold |
275,000
| – | – | 0.26% | 83 |
|
2019
Q2 | $905K | Hold |
275,000
| – | – | 0.24% | 85 |
|
2019
Q1 | $833K | Hold |
275,000
| – | – | 0.2% | 105 |
|
2018
Q4 | $781K | Hold |
275,000
| – | – | 0.15% | 135 |
|
2018
Q3 | $924K | Hold |
275,000
| – | – | 0.15% | 136 |
|
2018
Q2 | $710K | Hold |
275,000
| – | – | 0.12% | 174 |
|
2018
Q1 | $605K | Hold |
275,000
| – | – | 0.11% | 178 |
|
2017
Q4 | $547K | Hold |
275,000
| – | – | 0.11% | 191 |
|
2017
Q3 | $891K | Hold |
275,000
| – | – | 0.19% | 119 |
|
2017
Q2 | $886K | Hold |
275,000
| – | – | 0.2% | 115 |
|
2017
Q1 | $781K | Hold |
275,000
| – | – | 0.19% | 123 |
|
2016
Q4 | $641K | Hold |
275,000
| – | – | 0.17% | 130 |
|
2016
Q3 | $462K | Buy |
+275,000
| New | +$462K | 0.13% | 177 |
|
2015
Q4 | – | Sell |
-27,587
| Closed | -$47K | – | 317 |
|
2015
Q3 | $47K | Hold |
27,587
| – | – | 0.02% | 274 |
|
2015
Q2 | $57K | Sell |
27,587
-550
| -2% | -$1.14K | 0.02% | 290 |
|
2015
Q1 | $76K | Hold |
28,137
| – | – | 0.03% | 282 |
|
2014
Q4 | $72K | Hold |
28,137
| – | – | 0.03% | 260 |
|
2014
Q3 | $51K | Sell |
28,137
-22,413
| -44% | -$40.6K | 0.02% | 266 |
|
2014
Q2 | $135K | Hold |
50,550
| – | – | 0.05% | 271 |
|
2014
Q1 | $177K | Hold |
50,550
| – | – | 0.07% | 247 |
|
2013
Q4 | $226K | Hold |
50,550
| – | – | 0.09% | 219 |
|
2013
Q3 | $205K | Hold |
50,550
| – | – | 0.09% | 228 |
|
2013
Q2 | $210K | Buy |
+50,550
| New | +$210K | 0.1% | 205 |
|